Immorta Bio to Present SenoVax™ Cancer Senolytic Immunotherapy Preclinical Data at American Association of Immunologists Meeting

Seeking Alpha / 1 Views

Longevity Company to Present alongside Pfizer and University of Pittsburgh at Clinical Immunology Symposium MIAMI, May 5, 2025 /PRNewswire/ -- Immorta Bio Inc, a scientific longevity company dedicated to "Treating Diseases of Aging and Treating Aging as Disease", announced it is...

Comments